Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...

Christopher Nolan’s next project is an adaptation of The Odyssey, and though Oppenheimer is his biggest project to date, his ...

On Friday, Oppenheimer analysts maintained a Perform ... Plug Power has successfully concluded a three-year process to secure a $1.66 billion financing arrangement, which is poised to support ...

Investing.com -- Oppenheimer analysts warned that Tesla (NASDAQ: TSLA) faces rising risks as competition in both electric and ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.

Oppenheimer analyst Param Singh initiated coverage of IBM stock with an Outperform rating and a $320 price target.

Trump’s decision to shut down the USAID foreign aid agency will leave many pro-democracy groups abroad without funding.

PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $10.7 million or $1.04 basic ...

Peter Oppenheimer, the chief of global equity strategy and the head of macro research for Goldman Sachs in Europe, opined ...